The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol

類似資料

• LDL Cholesterol, Statins And PCSK 9 Inhibitors
  著者:: Gupta, Sanjiv
  出版事項: (2015)
• The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy
  著者:: Feng, QiPing, 等
  出版事項: (2016)
• PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke
  著者:: Rousselet, Estelle, 等
  出版事項: (2011)
• Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9
  著者:: van der Tuin, Sam J. L., 等
  出版事項: (2015)
• Hepatic Glucagon Signaling Regulates PCSK9 and LDL-Cholesterol
  著者:: Spolitu, Stefano, 等
  出版事項: (2019)